tiprankstipranks
Trending News
More News >
C4 Therapeutics (CCCC)
NASDAQ:CCCC
US Market

C4 Therapeutics (CCCC) Revenue

Compare
489 Followers

C4 Therapeutics Revenue

C4 Therapeutics had a revenue of 5.18M in the quarter ending Dec 31, 2024, with -66.30%. This bring the company's revenue in the last twelve months to 35.58M, Decreased 5.69%. In the fiscal year ending Dec 31, 2023, C4 Therapeutics had annual revenue of 20.76M with -33.25% growth.
Revenue (ttm)
35.58M
Revenue Growth
71.44%
P/S Ratio
5.34
Revenue/Employee
$188,691
Employees
110
Market Cap
$110.77M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202320.76M-10.34M-33.25%
Dec 31, 202231.10M-14.69M-32.08%
Dec 31, 202145.78M12.59M+37.93%
Dec 31, 202033.20M11.81M+55.25%
Dec 31, 201921.38M2.02M+10.42%
Dec 31, 201819.36M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis